CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF

CGF - CHALLENGER LIMITED

FNArena Sector : Wealth Management & Investments
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.54

30 Apr
2026

0.080

OPEN

$8.44

0.95%

HIGH

$8.56

1,497,050

LOW

$8.40

TARGET
$9.58 12.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 28.0 66.2 xxx
DPS (cps) xxx 29.5 31.0 xxx
EPS Growth xxx 47.5% 100.0% xxx
DPS Growth xxx 11.3% 5.1% xxx
PE Ratio xxx N/A 13.2 xxx
Dividend Yield xxx N/A 3.5% xxx
Div Pay Ratio(%) xxx 105.4% 46.8% xxx

Dividend yield today if purchased 3 years ago: 4.83%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.38

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - ex-div 15.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx28.0
DPS All xxxxxxxxxxxxxxx29.5
Sales/Revenue xxxxxxxxxxxxxxx3,116.1 M
Book Value Per Share xxxxxxxxxxxxxxx563.7
Net Operating Cash Flow xxxxxxxxxxxxxxx399.6 M
Net Profit Margin xxxxxxxxxxxxxxx6.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx4.97 %
Return on Invested Capital xxxxxxxxxxxxxxx3.62 %
Return on Assets xxxxxxxxxxxxxxx0.56 %
Return on Equity xxxxxxxxxxxxxxx4.97 %
Return on Total Capital xxxxxxxxxxxxxxx9.99 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx208.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx6,936 M
Long Term Debt xxxxxxxxxxxxxxx1,332 M
Total Debt xxxxxxxxxxxxxxx8,268 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx650 M
Price To Book Value xxxxxxxxxxxxxxx1.43

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx0.01 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx802 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx32,809 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

22/04/2026

1

Buy

$10.10

18.27%

UBS explains Challenger's 3Q26 update showed solid Life momentum, with sales of $1.72bn up 19% y/y and 14% ahead of forecasts, driven by stronger Challenger Index Plus flows and higher-quality growth in longer-duration annuities.

Life capital remained robust, with improving market conditions and upcoming APRA rule changes supporting potential 'Day 1' returns of $300m and an additional circa $300m upside to capital management capacity, lifting total buyback potential to around $1.3bn, the analyst explains.

Funds Management disappointed the broker, with AUM down -10% to $104.5bn on elevated net outflows of -$8.0bn. EPS forecasts are downgraded slightly.

Buy rating retained with a higher target of $10.10 from $10.05.

FORECAST
UBS forecasts a full year FY26 dividend of 31.00 cents and EPS of 63.00 cents.
UBS forecasts a full year FY27 dividend of 37.00 cents and EPS of 67.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

21/04/2026

3

Neutral

$8.70

1.87%

Challenger is rated Neutral with an $8.70 price target at Jarden, with no changes made following the 3Q26 update.

The broker observes group sales missed consensus across key metrics while funds management outflows were significantly worse than expected.

Commentary posits the planned redemption of all capital notes on 25 May 2026 provides a headline positive offset by simplifying the capital structure and reducing coupon burdens.

The analysts expect this redemption to be accretive to earnings while providing future capital management flexibility under potential regulatory reforms.

Investors face balanced risk and reward as persistent outflows compete with expanding retirement partnerships across superfunds.

FORECAST
Jarden forecasts a full year FY26 dividend of 31.00 cents and EPS of 67.80 cents.
Jarden forecasts a full year FY27 dividend of 34.00 cents and EPS of 75.30 cents.
Access Extra Coverage Research History >

CGF STOCK CHART

FNArena News on CGF

Latest Wealth Management & Investments News

1
SMSFundamentals: SMAs Hot, Retail Funds Not

Jun 07 2022 - SMSFundamentals
2
Pendal Navigates Volatility With Cost Control

May 13 2022 - Australia
3
In Brief: Debt Doubles, Investment Markets, Homewares Retail

Apr 08 2022 - Weekly Reports
4
Treasure Chest: Undervalued Fund Managers

Mar 21 2022 - Treasure Chest
5
Margins Give Hub24 An Edge on Competitors

Feb 28 2022 - Australia
6
Macquarie On Watch

Feb 01 2022 - Technicals
7
Hub24: More Patience Required

Jan 11 2022 - Technicals
8
More Mandate Losses Expected For Magellan

Dec 22 2021 - Australia
9
Australian Super Offering Lower Fees, Better Returns

Nov 02 2021 - Australia
10
Has The Market Over-Reacted To Pendal Group?

Oct 18 2021 - Australia